In prostate cancer cells exogenous supplementation of IGFBP-3 resulted in induction of apoptosis through the export of orphan nuclear receptors, Nur77 and its binding partner, RXR-α (Agostini-Dreyer et al., 2015). Here, IGFBP3 is linked to prostate carcinoma.